-
Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.
JAMA. 2003 Aug 13;290(6):765-72
PMID: 12915429
-
Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle.
J Biol Chem. 2003 Oct 3;278(40):39124-32
PMID: 12865425
-
The enzymes, regulation, and genetics of bile acid synthesis.
Annu Rev Biochem. 2003;72:137-74
PMID: 12543708
-
Mitochondrial dysfunction and type 2 diabetes.
Science. 2005 Jan 21;307(5708):384-7
PMID: 15662004
-
Regulation of carbohydrate metabolism by the farnesoid X receptor.
Endocrinology. 2005 Mar;146(3):984-91
PMID: 15564327
-
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
Biochem Biophys Res Commun. 2005 Apr 1;329(1):386-90
PMID: 15721318
-
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition.
J Biol Chem. 2005 Aug 19;280(33):29971-9
PMID: 15899888
-
Farnesoid X receptor: from structure to potential clinical applications.
J Med Chem. 2005 Aug 25;48(17):5383-403
PMID: 16107136
-
The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2020-30
PMID: 16037564
-
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
Cell Metab. 2005 Oct;2(4):217-25
PMID: 16213224
-
The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes.
Cell Metab. 2005 Oct;2(4):227-38
PMID: 16213225
-
Is antagonism of E/Z-guggulsterone at the farnesoid X receptor mediated by a noncanonical binding site? A molecular modeling study.
J Med Chem. 2005 Nov 3;48(22):6948-55
PMID: 16250653
-
FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.
J Lipid Res. 2006 Jan;47(1):201-14
PMID: 16251721
-
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1006-11
PMID: 16410358
-
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
Nature. 2006 Jan 26;439(7075):484-9
PMID: 16400329
-
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.
Genes Dev. 2003 Jul 1;17(13):1581-91
PMID: 12815072
-
Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes.
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13656-61
PMID: 10570128
-
Identification of a chemical tool for the orphan nuclear receptor FXR.
J Med Chem. 2000 Aug 10;43(16):2971-4
PMID: 10956205
-
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.
Mol Cell. 2000 Sep;6(3):507-15
PMID: 11030331
-
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.
Mol Cell. 2000 Sep;6(3):517-26
PMID: 11030332
-
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
Cell. 2000 Sep 15;102(6):731-44
PMID: 11030617
-
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
Genes Dev. 2000 Nov 15;14(22):2819-30
PMID: 11090130
-
Role of LXRs in control of lipogenesis.
Genes Dev. 2000 Nov 15;14(22):2831-8
PMID: 11090131
-
The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity.
Mol Endocrinol. 2002 Sep;16(9):2065-76
PMID: 12198243
-
Bile acid regulation of gene expression: roles of nuclear hormone receptors.
Endocr Rev. 2002 Aug;23(4):443-63
PMID: 12202460
-
Identification of membrane-type receptor for bile acids (M-BAR).
Biochem Biophys Res Commun. 2002 Nov 15;298(5):714-9
PMID: 12419312
-
Nuclear receptors and the control of metabolism.
Annu Rev Physiol. 2003;65:261-311
PMID: 12518001
-
Identification of gene-selective modulators of the bile acid receptor FXR.
J Biol Chem. 2003 Feb 28;278(9):7027-33
PMID: 12496277
-
A G protein-coupled receptor responsive to bile acids.
J Biol Chem. 2003 Mar 14;278(11):9435-40
PMID: 12524422
-
Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.
J Biol Chem. 2003 Mar 21;278(12):10214-20
PMID: 12525500
-
Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes.
Mol Cell Biol. 2003 May;23(9):3052-66
PMID: 12697808
-
Genetic variation in the small heterodimer partner gene and young-onset type 2 diabetes, obesity, and birth weight in U.K. subjects.
Diabetes. 2003 May;52(5):1276-9
PMID: 12716764
-
Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations.
Diabetes. 2003 May;52(5):1288-91
PMID: 12716767
-
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.
Mol Cell. 2003 Apr;11(4):1079-92
PMID: 12718892
-
Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects.
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):575-80
PMID: 11136233
-
Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway.
J Biol Chem. 2001 May 11;276(19):15816-22
PMID: 11278771
-
Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
Mol Endocrinol. 2001 Oct;15(10):1720-8
PMID: 11579204
-
Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.
Endocrinology. 2002 May;143(5):1741-7
PMID: 11956156
-
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.
J Clin Invest. 2002 May;109(9):1125-31
PMID: 11994399
-
A natural product that lowers cholesterol as an antagonist ligand for FXR.
Science. 2002 May 31;296(5573):1703-6
PMID: 11988537
-
Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.
Dev Cell. 2002 Jun;2(6):713-20
PMID: 12062084
-
Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
J Clin Invest. 2003 Dec;112(11):1678-87
PMID: 14623915
-
Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR.
Genes Dev. 2004 Jan 15;18(2):157-69
PMID: 14729567
-
Glucose regulates the expression of the farnesoid X receptor in liver.
Diabetes. 2004 Apr;53(4):890-8
PMID: 15047603
-
PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.
Nat Med. 2004 May;10(5):530-4
PMID: 15107844
-
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.
J Clin Invest. 2004 May;113(10):1408-18
PMID: 15146238
-
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1.
J Biol Chem. 2004 May 28;279(22):23158-65
PMID: 15047713
-
The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner.
Biochem J. 2004 Sep 15;382(Pt 3):913-21
PMID: 15202934
-
The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts.
Ann Med. 2004;36(7):482-91
PMID: 15513299
-
Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism.
J Lab Clin Med. 1971 Jul;78(1):94-121
PMID: 5569253
-
Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia.
Lancet. 1974 Oct 19;2(7886):929-31
PMID: 4138590
-
Changes in plasma triglyceride metabolism during withdrawal of bile.
Metabolism. 1976 Nov;25(11):1259-68
PMID: 185488
-
Circadian distribution of bile acid in the enterohepatic circulatory system in hamsters.
J Lipid Res. 1976 Nov;17(6):600-4
PMID: 993671
-
Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia.
J Lipid Res. 1978 Nov;19(8):1017-24
PMID: 731123
-
Within-day fluctuations in serum bile-acid concentrations among normal control subjects and patients with hepatic disease.
Am J Clin Pathol. 1980 Feb;73(2):196-201
PMID: 7188830
-
Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety.
Ann Intern Med. 1981 Sep;95(3):257-82
PMID: 7023307
-
Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Scand J Gastroenterol. 1982 Aug;17(5):587-92
PMID: 7178821
-
Steady-state kinetics of serum bile acids in healthy human subjects: single and dual isotope techniques using stable isotopes and mass spectrometry.
J Lipid Res. 1987 Mar;28(3):238-52
PMID: 3553403
-
Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
Ann Intern Med. 1994 Sep 15;121(6):416-22
PMID: 8053615
-
Identification of a nuclear receptor that is activated by farnesol metabolites.
Cell. 1995 Jun 2;81(5):687-93
PMID: 7774010
-
Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease.
Am J Physiol. 1997 Jul;273(1 Pt 1):E37-45
PMID: 9252477
-
ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.
Mol Cell Biol. 1999 May;19(5):3760-8
PMID: 10207099
-
Identification of a nuclear receptor for bile acids.
Science. 1999 May 21;284(5418):1362-5
PMID: 10334992
-
Bile acids: natural ligands for an orphan nuclear receptor.
Science. 1999 May 21;284(5418):1365-8
PMID: 10334993
-
Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.
Mol Cell. 1999 May;3(5):543-53
PMID: 10360171
-
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.
Nat Med. 2004 Dec;10(12):1352-8
PMID: 15558057
-
Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.
J Pharmacol Exp Ther. 2005 Jan;312(1):170-8
PMID: 15329387
-
Redundant pathways for negative feedback regulation of bile acid production.
Dev Cell. 2002 Jun;2(6):721-31
PMID: 12062085
-
The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor.
Mol Endocrinol. 2002 Jul;16(7):1590-7
PMID: 12089353